机构

• 宁波材料技术与工程研... [2]
• 上海药物研究所 [2]
• 大连化学物理研究所 [2]
• 合肥物质科学研究院 [2]
• 地理科学与资源研究所 [1]
• 自动化研究所 [1]
• 更多

采集方式

• OAI收割 [10]

内容类型

• 期刊论文 [10]

发表日期

• 2023 [2]
• 2022 [1]
• 2021 [2]
• 2020 [1]
• 2017 [2]
• 2016 [1]
• 更多

学科主题

• Engineerin... [1]
• Materials ... [1]

筛选

浏览/检索结果: 共10条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 A validated LC-MS/MS method for the quantification of bevacizumab in rat, cynomolgus monkey, and human serum 期刊论文  OAI收割 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2023, 卷号: 235, 页码: 11 作者:  Zhou, Ainan;  Yu, Jinghua;  Wu, Yali;  Xue, Hao;  Zhong, Dafang   |  收藏  |  浏览/下载：21/0  |  提交时间：2023/10/17 Monoclonal antibody  Bevacizumab  LC-MS  MS  Surrogate peptide  Pharmacokinetics  Serum   Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study 期刊论文  OAI收割 BMC CANCER, 2023, 卷号: 23 作者:  Cao, Fei;  Shi, Changsheng;  Zhang, Guofu;  Luo, Jun;  Zheng, Jiaping   |  收藏  |  浏览/下载：21/0  |  提交时间：2023/11/10 Hepatocellular carcinoma  Atezolizumab  Bevacizumab  Overall survival  Progression-free survival   Modeling the efficacy of different anti-angiogenic drugs on treatment of solid tumors using 3D computational modeling and machine learning 期刊论文  OAI收割 COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 卷号: 146, 页码: 16 作者:  Mousavi, Milad;  Manshadi, Mahsa Dehghan;  Soltani, Madjid;  Kashkooli, Farshad M.;  Rahmim, Arman   |  收藏  |  浏览/下载：40/0  |  提交时间：2022/09/21 Solid tumor  Tumor growth  Anti-angiogenic drugs  Bevacizumab  Ranibizumab  Brolucizumab  Artificial intelligence  Cancer   Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy 期刊论文  OAI收割 EUROPEAN JOURNAL OF RADIOLOGY, 2021, 卷号: 142, 页码: 8 作者:  Wei, Shengcai;  Han, Yuqi;  Zeng, Hanjiang;  Ye, Shuai;  Cheng, Jin   |  收藏  |  浏览/下载：67/0  |  提交时间：2021/11/03 Histopathologic growth pattern  Colorectal liver metastases  Unresectable  Radiomics  Bevacizumab   Original Research Paper Synthetic anti-angiogenic genomic therapeutics for treatment of neovascular age-related macular degeneration 期刊论文  OAI收割 ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 卷号: 16, 期号: 5, 页码: 623-632 作者:  Wang, Jing;  Shi, Xiang;  Bo, Qiyu;  Wang, Hong;  Wei, Fang   |  收藏  |  浏览/下载：23/0  |  提交时间：2021/12/01 CHOROIDAL NEOVASCULARIZATION  GENE-THERAPY  BEVACIZUMAB  RANIBIZUMAB  INHIBITION   Small-sized gadolinium oxide based nanoparticles for high-efficiency theranostics of orthotopic glioblastoma 期刊论文  OAI收割 BIOMATERIALS, 2020, 卷号: 235 作者:  Shen, Zheyu;  Liu, Ting;  Yang, Zhen;  Zhou, Zijian;  Tang, Wei   |  收藏  |  浏览/下载：49/0  |  提交时间：2020/12/16 BLOOD-BRAIN-BARRIER  CONTRAST AGENTS  GOLD NANOPARTICLES  DRUG-DELIVERY  BEVACIZUMAB  THERAPY  T-1  PERMEABILITY  RADIOTHERAPY  TEMOZOLOMIDE   Characterization, Quantification and Pharmacokinetic Analysis of Bevacizumab and Its Glycosylation by Mass Spectrometry 期刊论文  OAI收割 CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 2017, 卷号: 45, 期号: 11, 页码: 1678-1685 作者:  Ye Ming-Liang;  Zou Han-Fa;  Cong Yu-Ting;  Hu Liang-Hai;  Gu Jing-Kai   |  收藏  |  浏览/下载：38/0  |  提交时间：2019/06/20 Bevacizumab  Glycosylation  Liquid Chromatography-tandem Mass Spectrometry  Parallel Reaction  Monitoring  Pharmacokinetics   1256dianhydrogalactitolinhibitshumangliomacellgrowthinvivoandinvitrobyarrestingthecellcycleatg2mphase 期刊论文  OAI收割 actapharmacologicasinica, 2017, 卷号: 38, 期号: 4, 页码: 561 作者:  Peng Chun;  Ql Xinming   |  收藏  |  浏览/下载：21/0  |  提交时间：2020/07/01 NEWLY-DIAGNOSED GLIOBLASTOMA  DNA-DAMAGE  RANDOMIZED-TRIAL  DIANHYDROGALACTITOL  TEMOZOLOMIDE  P53  CANCER  TUMORS  BEVACIZUMAB  COMBINATION  1,2:5,6-dianhydrogalactitol  human glioblastoma  cell cycle arrest  p53-p21 cascade  CDC25C-CDK1 cascade  radiosensitivity  xenografted tumors   Expert consensus on maintenance treatment for metastatic colorectal cancer in China 期刊论文  OAI收割 CHINESE JOURNAL OF CANCER, 2016, 卷号: 35 -   |  收藏  |  浏览/下载：10/0  |  提交时间：2020/10/26 BEVACIZUMAB  CAPECITABINE  THERAPY  XELOX  CHEMOTHERAPY  OXALIPLATIN  TRIAL  STOP  GO  Metastatic colorectal cancer  Maintenance therapy  Consensus   Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy 期刊论文  OAI收割 oncotarget, 2015, 卷号: 6, 期号: 14, 页码: 11882-11893 作者:  Xu, Hui;  Rahimpour, Shervin;  Nesvick, Cody L.;  Zhang, Xu;  Ma, Jingyun 收藏  |  浏览/下载：37/0  |  提交时间：2015/11/17 glioblastoma  bevacizumab  epithelial-mesenchymal transition  pathologic angiogenesis  hypoxia-inducible factor